Synthesis and Structure-Activity Relationships of TAN-1511 Analogues as Potent Hematopoietic Agents
スポンサーリンク
概要
- 論文の詳細を見る
A series of TAN-1511 analogues bearing a non-peptide spacer in place of the Gly-Gly-Gly sequence in the peptide moiety was synthesized, and the effects of these compounds on the proliferation of bone marrow cells in culture and experimental leukocytopenia in mice were examined. The structure-activity relationships obtained were as follows. As the substituent at the 2-position of the 4-thiaheptanoic acid framework, an amino group, methyl group or hydrogen was preferable; as a spacer in place of the Gly-Gly-Gly sequence, a 4-aminobenzoyl or 4-aminomethylbenzoyl group was suitable; and as the fatty acids bonded to the 6,7-dihydroxy groups, C_<16> fatty acid was best. Compounds 12f, 30d and 30i potently promoted the proliferation of bone marrow cells in culture and the restoration of leukocyte counts in a murine leukocytopenia model.
- 公益社団法人日本薬学会の論文
- 1998-02-15
著者
-
Itoh F
Division Of Gastroenterology And Hepatology Department Of Internal Medicine St Marianna University S
-
Itoh Fumio
Division Of Gastroenterology And Hepatology Department Of Internal Medicine St Marianna University S
-
TANIDA Seiichi
Discovery Research Division, Takeda Chemical Industries, Ltd.
-
NISHIKIMI Yuji
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
Nishikimi Y
Takeda Chemical Ind. Ltd. Osaka Jpn
-
Nishikimi Yuji
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Itoh Fumio
Pharmaceutical Research Laboratories Iii. Takeda Chemical Industries Ltd.
-
Itoh Fumio
Pharmaceutical Research Division Takeda Chemical Industries Ltd.
-
Tanida S
Discovery Research Laboratories Takeda Chemical Industries Ltd.
-
Tanida Seiichi
Discovery Research Division Takeda Chemical Industries Ltd.
-
YOSHIOKA Yoshio
Medicinal Chemistry Research Laboratories, Takeda Chemical Industries, Ltd.,
-
YUKISHIGE Koichi
Pharmaceutical Business Development Department Takeda Chemical Industries, Ltd.,
-
YOSHIOKA Yoshio
Pharmaceutical Research Laboratories III, Takeda Chemical Industries, Ltd.
-
Ypshioka Y
Medicinal Chemistry Research Laboratories Takeda Chemical Industries Ltd.
-
HASUOKA Atsushi
Pharmaceutical Research Laboratories II Takeda Chemical Industries, Ltd.,
-
AONO Tetsuya
Pharmaceutical Research Laboratories II Takeda Chemical Industries, Ltd.,
-
Aono T
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Hasuoka Atsushi
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Yukishige K
Pharmaceutical Business Development Department Takeda Chemical Industries Ltd.
関連論文
- Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C
- Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B
- Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response
- Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis
- Microbial Conversion of EM574 and EM523, Gastrointestinal motor Stimulating Agents
- Effect of treatment with interferon α-2b and ribavirin in patients infected with genotype 2 hepatitis C virus
- A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C
- Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder
- Optically Active Cyclohexene Derivative as a New Antisepsis Agent : An Efficient Synthesis of Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)-sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242)
- Divergent roles of tumor suppressor gene Klf6 in ES cell differentiation
- Synthesis and Anti-Helicobacter pylori Activity of Pyloricidin Derivatives II. The Combination of Amino Acid Residues in the Dipeptidic Moiety and its Effect on the Anti-Helicobacter pylori Activity
- Synthesis and Anti-Helicobacter pylori Activity of Pyloricidin Derivatives : I. Structure-activity Relationships on the Terminal Peptidic Moiety
- Total Synthesis of Novel Antibiotics Pyloricidin A, B and C and Their Application in the Study of Pyloricidin Derivatives
- Non-glutamate Type Pyrrolo[2,3-d]pyrimidine Antifolates. III. Synthesis and Biological Properties of N^ω-Masked Ornithine Analogs
- Non-glutamate Type Pyrrolo[2,3-d]pyrimidine Antifolates. II. Synthesis and Antitumor Activity of N^5-Substituted Glutamine Analogs
- Enzyme-inhibition system for identifying potential antimalarials that target highly drug-resistant mutants of Plasmodium falciparum dihydrofolate reductase
- Epigenetics modulates the effect of chemotherapy on gastric cancer
- Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease
- Synthesis and Structure-Activity Relationships of TAN-1511 Analogues as Potent Hematopoietic Agents
- Synthesis and Biological Activities of TAN-1511 Analogues
- TAN-1511 A, B and C, Microbial Lipopeptides with G-CSF and GM-CSF Inducing Activity
- In Vivo Biological Activity of Antioxidative Aminothiazole Derivatives
- Antitumor Effects of 5'-Deoxy-5-fluorouridine in Combination with Recombinant Human Interleukin 2 on Murine Colon Carcinoma 26
- Pyrrolo[2, 3-d]pyrimidine Thymidylate Synthase Inhibitors : Design and Synthesis of One-Carbon Bridge Derivatives
- Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography : can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?